All In Biotech

Free tool

FAERS Monitor: Pentasa

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020049 or its brand name (Pentasa, Mesalamine). Reports on generic versions are filed under their own applications.

Reports

43,912

Serious

36,874

84% of reports

Hospitalization

15,081

Death reported

2,603

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use8,661
  • drug ineffective5,980
  • colitis ulcerative5,816
  • condition aggravated4,320
  • diarrhoea3,945
  • abdominal pain3,208
  • fatigue3,198
  • haematochezia3,172
  • nausea2,748
  • headache2,623
  • pyrexia2,548
  • weight decreased2,528
  • crohn^s disease2,493
  • arthralgia2,436
  • frequent bowel movements2,307

Reports by year received

View as table
YearReports
2004339
2005372
2006354
2007453
2008754
2009588
2010688
20111,353
20121,565
20131,133
20141,274
20151,355
20161,237
20171,047
20181,385
20191,647
20202,189
20213,496
20225,122
20235,137
20244,860
20254,753
20262,809

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,010,247 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

FDA's data service returned an error (400). The numbers below may be missing or incomplete.
ReactionReportsPRR95% CI lowerChi-squared
colitis ulcerativeSignal5,81671.569.7352,357
frequent bowel movementsSignal2,30744.642.890,074
haematocheziaSignal3,17229.128.181,435
condition aggravatedSignal4,3206.96.721,749
abdominal painSignal3,2086.76.515,456
off label useSignal8,6614.84.726,700
weight decreasedSignal2,5284.44.26,590
pyrexiaSignal2,5483.53.44,698
diarrhoeaSignal3,9452.92.95,173
arthralgiaSignal2,4362.82.72,893
drug ineffectiveSignal5,9802.22.14,049
headacheSignal2,6232.01.91,362
fatigue3,1982.01.91,582
nausea2,7481.71.6756
crohn^s disease2,4930.00.01,192,469

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.